Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update

NEXT STORY
Medicenna Announces the Peer-Reviewed Publication of Clinical Data from Phase 2b Trial Evaluating MDNA55 in Recurrent Glioblastoma
PREV STORY
Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

ACR Recommends CMS Make Drug Pricing Demonstration Voluntary; Better Address Financial and Administrative Challenges ...

author_avatar
NASDAQ Market News

Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association

author_avatar
NASDAQ Market News

AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-101 in SMA Type 1 at the Annual Meeting of the American Academy of Neurology

author_avatar
NASDAQ Market News